NAD+ Precursors (NMN/NR) vs SIRT1-Activating Peptide
Research Verdict
NAD+ Precursors (NMN/NR) is the stronger research reference for the stated comparison criteria. NAD+ (via NR/NMN): multiple human RCTs showing NAD+ level increases (Martens et al.
Quick Answers
Which is better, NAD+ Precursors (NMN/NR) or SIRT1-Activating Peptide?
NAD+ Precursors (NMN/NR) is the stronger research reference for the stated comparison criteria. NAD+ (via NR/NMN): multiple human RCTs showing NAD+ level increases (Martens et al.
What is the key difference between NAD+ Precursors (NMN/NR) and SIRT1-Activating Peptide?
NAD+ precursors raise a measurable metabolite with a known biochemical role; SIRT1 activators target a specific enzyme whose druggability and therapeutic relevance in humans remains debated.
Evidence Comparison
NAD+ (via NR/NMN): multiple human RCTs showing NAD+ level increases (Martens et al. 2018, Yoshino et al. 2021); functional clinical endpoints remain mixed. SIRT1 activators: resveratrol failed to show consistent SIRT1-dependent effects in humans; SRT2104 had early-phase data but the program was discontinued. NAD+ precursors have meaningfully stronger human data.
Evidence Context Favoring NAD+ Precursors (NMN/NR)
Research into NAD+ metabolism, cellular energetics, or aging biomarkers where human pharmacokinetic confirmation of target engagement exists.
Evidence Context Favoring SIRT1-Activating Peptide
Mechanistic research specifically investigating sirtuin biology - but no clinically validated SIRT1 activator exists as of 2026.
Side-by-Side Snapshot
| Evidence grade | NAD+ Precursors (NMN/NR): Level B SIRT1-Activating Peptide: Level D |
|---|---|
| Research status | NAD+ Precursors (NMN/NR): Phase 2 SIRT1-Activating Peptide: Early Research |
| Primary category | NAD+ Precursors (NMN/NR): Anti-Aging & Longevity SIRT1-Activating Peptide: Anti-Aging & Longevity |
| Cited studies | NAD+ Precursors (NMN/NR): 3 SIRT1-Activating Peptide: 2 |